I-Tech AB is a biotechnology company. The company owns all IP and regulatory rights to the antifouling agent Selektope. Its business is to commercialize patented active substances to reduce marine fouling on hulls, gears, and other submerged structures.
2000
11
LTM Revenue $20.0M
LTM EBITDA $6.5M
$115M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
I-Tech has a last 12-month revenue of $20.0M and a last 12-month EBITDA of $6.5M.
In the most recent fiscal year, I-Tech achieved revenue of $18.5M and an EBITDA of $5.9M.
I-Tech expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See I-Tech valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $12.5M | $18.5M | XXX | XXX | XXX |
Gross Profit | $4.7M | $6.5M | XXX | XXX | XXX |
Gross Margin | 37% | 35% | XXX | XXX | XXX |
EBITDA | $3.4M | $5.9M | XXX | XXX | XXX |
EBITDA Margin | 28% | 32% | XXX | XXX | XXX |
Net Profit | $1.1M | $2.1M | XXX | XXX | XXX |
Net Margin | 9% | 11% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, I-Tech's stock price is SEK 101 (or $10).
I-Tech has current market cap of SEK 1.2B (or $124M), and EV of SEK 1.1B (or $115M).
See I-Tech trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$115M | $124M | XXX | XXX | XXX | XXX | $0.42 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, I-Tech has market cap of $124M and EV of $115M.
I-Tech's trades at 5.8x LTM EV/Revenue multiple, and 17.6x LTM EBITDA.
Analysts estimate I-Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for I-Tech and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $115M | XXX | XXX | XXX |
EV/Revenue | 6.2x | XXX | XXX | XXX |
EV/EBITDA | 19.5x | XXX | XXX | XXX |
P/E | 30.8x | XXX | XXX | XXX |
P/E/Growth | 0.8x | XXX | XXX | XXX |
EV/FCF | 32.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialI-Tech's NTM/LTM revenue growth is 21%
I-Tech's revenue per employee for the last fiscal year averaged $1.7M, while opex per employee averaged n/a for the same period.
Over next 12 months, I-Tech's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate I-Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for I-Tech and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 48% | XXX | XXX | XXX | XXX |
EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
EBITDA Growth | 72% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 1% | XXX | XXX | XXX | XXX |
Revenue per Employee | $1.7M | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
I-Tech acquired XXX companies to date.
Last acquisition by I-Tech was XXXXXXXX, XXXXX XXXXX XXXXXX . I-Tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was I-Tech founded? | I-Tech was founded in 2000. |
Where is I-Tech headquartered? | I-Tech is headquartered in Sweden. |
How many employees does I-Tech have? | As of today, I-Tech has 11 employees. |
Is I-Tech publicy listed? | Yes, I-Tech is a public company listed on STO. |
What is the stock symbol of I-Tech? | I-Tech trades under ITECH ticker. |
When did I-Tech go public? | I-Tech went public in 2018. |
Who are competitors of I-Tech? | Similar companies to I-Tech include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
What is the current market cap of I-Tech? | I-Tech's current market cap is $124M |
What is the current revenue of I-Tech? | I-Tech's last 12-month revenue is $20.0M. |
What is the current EBITDA of I-Tech? | I-Tech's last 12-month EBITDA is $6.5M. |
What is the current EV/Revenue multiple of I-Tech? | Current revenue multiple of I-Tech is 5.8x. |
What is the current EV/EBITDA multiple of I-Tech? | Current EBITDA multiple of I-Tech is 17.6x. |
What is the current revenue growth of I-Tech? | I-Tech revenue growth between 2023 and 2024 was 48%. |
Is I-Tech profitable? | Yes, I-Tech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.